FundedIQ
Biotechnology

HeMemics Biotechnologies, Inc.: Funding, Investors & Team (Oct 2026)

www.hememics.com LinkedIn Gaithersburg, United States 1-10 employees
Biotechnology Health Care Health Diagnostics Medical Device B2B
Total raised
$2.3M
Rounds
2
Latest
Undisclosed round
Mar 2025

HeMemics Biotechnologies, Inc. has raised $2.3M across 2 funding rounds on record, the most recent an undisclosed round of $250k announced in Mar 2025.

That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

HeMemics Biotechnologies, Inc. Company Profile and Key Stats

Total funding raised
$2.3M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$250k in Mar 2025
Employees
1-10
reported band
Headquarters
Gaithersburg, United States

Latest funding round on record: Mar 2025.

HeMemics Biotechnologies, Inc. Funding Rounds

Date
Round
Amount
Undisclosed round
$250k
Seed
$2.0M

HeMemics Biotechnologies, Inc. raised $2.0M in a Seed announced in May 2023.

1.8 years later, an undisclosed round of $250k was announced in Mar 2025.

HeMemics Biotechnologies, Inc. Founders and Leadership Team

Name
Role
Contact
David Ho Huy
Founder
Locked
John Warden
CEO
Locked

Contact details for the HeMemics Biotechnologies, Inc. team: 2 of 2 have an email address on file.

Start 14-day free trial →

HeMemics Biotechnologies, Inc. Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M

HeMemics Biotechnologies, Inc.'s latest round of $250k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like HeMemics Biotechnologies, Inc. in Biotechnology and Gaithersburg

Companies Similar to HeMemics Biotechnologies, Inc.

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

HeMemics Biotechnologies, Inc. Funding FAQs

How much funding has HeMemics Biotechnologies, Inc. raised?

HeMemics Biotechnologies, Inc. has raised $2.3M across 2 rounds on record. The most recent is an undisclosed round of $250k announced in Mar 2025.

When did HeMemics Biotechnologies, Inc. last raise funding?

HeMemics Biotechnologies, Inc.'s most recent funding round on record is an undisclosed round of $250k, announced in Mar 2025.

Who founded HeMemics Biotechnologies, Inc.?

FundedIQ lists David Ho Huy (Founder) at HeMemics Biotechnologies, Inc..

Who is the CEO of HeMemics Biotechnologies, Inc.?

John Warden is listed as CEO at HeMemics Biotechnologies, Inc..

Where is HeMemics Biotechnologies, Inc. headquartered?

HeMemics Biotechnologies, Inc. is based in Gaithersburg, Maryland, United States.

How many employees does HeMemics Biotechnologies, Inc. have?

HeMemics Biotechnologies, Inc. is in the 1-10 employee band.

How does HeMemics Biotechnologies, Inc.'s funding compare to other Biotechnology startups?

HeMemics Biotechnologies, Inc.'s latest round of $250k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's HeMemics Biotechnologies, Inc. Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for HeMemics Biotechnologies, Inc. is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.